Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,575.50
(
0.29%
)
US TECH 100
23,617.80
(
1.11%
)
Dow Jones
46,237.78
(
0.25%
)
Brent Oil
97.85
(
1.40%
)
Bitcoin
70,629.99
(
0.16%
)
News Focus
News Focus
Post# of 30495
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 18153

Monday, 01/13/2020 12:52:42 PM

Monday, January 13, 2020 12:52:42 PM

Post# of 30495
ABT starts pivotal trial to expand MitraClip label to include patients at moderate risk for open-heart surgical repair:

https://finance.yahoo.com/news/abbott-initiate-trial-study-mitraclip-140000291.html

MitraClip is already a bona fide blockbuster product with rapid growth from the FDA’s Mar 2019 label expansion to secondary mitral regurgitation (#msg-147544267). The potential label expansion from the new trial described above would materially move the needle even further.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today